about
Targeted therapy using nanotechnology: focus on cancerVirtual Screening and Biological Validation of Novel Influenza Virus PA Endonuclease Inhibitors.Nanoencapsulation of natural triterpenoid celastrol for prostate cancer treatment.Single-step green synthesis and characterization of gold-conjugated polyphenol nanoparticles with antioxidant and biological activities.Design and synthesis of novel dihydroquinoline-3-carboxylic acids as HIV-1 integrase inhibitors.Inhibitory Effect of 2,3,5,6-Tetrafluoro-4-[4-(aryl)-1H-1,2,3-triazol-1-yl]benzenesulfonamide Derivatives on HIV Reverse Transcriptase Associated RNase H Activities.Ceftriaxone blocks the polymerization of α-synuclein and exerts neuroprotective effects in vitroAn integrated biological approach to guide the development of metal-chelating inhibitors of influenza virus PA endonuclease.HIV-1 IN strand transfer chelating inhibitors: a focus on metal binding.Carbonic Anhydrase Inhibition with Benzenesulfonamides and Tetrafluorobenzenesulfonamides Obtained via Click ChemistryDesign and synthesis of bis-amide and hydrazide-containing derivatives of malonic acid as potential HIV-1 integrase inhibitors.Targeted Nanoparticles for the Delivery of Novel Bioactive Molecules to Pancreatic Cancer Cells.Inhibition of α-class cytosolic human carbonic anhydrases I, II, IX and XII, and β-class fungal enzymes by carboxylic acids and their derivatives: new isoform-I selective nanomolar inhibitors.Effect of chitosan concentration on PLGA microcapsules for controlled release and stability of resveratrol.Nanoencapsulation of dietary flavonoid fisetin: Formulation and in vitro antioxidant and α-glucosidase inhibition activities.Investigating the role of metal chelation in HIV-1 integrase strand transfer inhibitors.Virtual screening-driven identification of human carbonic anhydrase inhibitors incorporating an original, new pharmacophorePeptidomimetics as protein arginine deiminase 4 (PAD4) inhibitorsPolymeric Nanoparticles Encapsulating White Tea Extract for Nutraceutical Application
P50
Q27023361-08CFA5FC-E5AA-4854-8849-F93850D0E481Q35960631-EFEFA70E-4789-494F-9C68-2AC42498C7F3Q38818143-63D28DD6-E540-4CEA-AF69-341A013A7F13Q38943270-18982ECA-CBD2-4B29-8680-5908FC7FD14EQ39913483-116EB07A-D809-47F7-B355-38FD9E8069A5Q40953028-65B54A62-EE2F-4FCC-98CF-B4D231A8E25EQ41877125-F7FD09F8-ED9A-4F6C-BF23-BC95191C07F5Q42177579-E603EB3A-ED72-4583-B338-290FA09AA463Q42750424-972D18E2-3A47-48B6-9E61-949FE018D633Q42808032-28550C51-BA3B-4DC2-A4A3-4F9AC639F5CCQ46335921-864F81C2-A485-4ABE-9DEA-B7C0A9039F3DQ46770005-012D9BAC-1B0B-4F9F-9CC1-AA1E97814F23Q50505081-9F124DB7-CC0C-4B7A-A125-6BE71B9183C4Q51053885-EAD54FB9-4842-4D49-8418-162CA4525688Q51200794-482390D6-B5A9-48AD-996C-40B05F5C2E39Q54551751-52408899-5BBF-4BC6-A445-A206D5E68332Q57266105-94DACDC6-443C-4227-B4D4-E9A8FC99B6A8Q58863151-50EEF78D-0457-4576-BE5D-1F8AAC507C01Q61054755-D28DA06F-E0FF-482E-9BB6-89D289A3AC2E
P50
description
hulumtues
@sq
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Nicolino Pala
@ast
Nicolino Pala
@en
Nicolino Pala
@es
Nicolino Pala
@nl
Nicolino Pala
@sl
type
label
Nicolino Pala
@ast
Nicolino Pala
@en
Nicolino Pala
@es
Nicolino Pala
@nl
Nicolino Pala
@sl
prefLabel
Nicolino Pala
@ast
Nicolino Pala
@en
Nicolino Pala
@es
Nicolino Pala
@nl
Nicolino Pala
@sl
P106
P1153
25633092400
P21
P31
P496
0000-0002-9681-5233